联康生物科技集团(00690.HK) 公布两项重要里程碑。集团与重庆民济医疗器械有限公司的战略合作产品-医用重组胶原蛋白敷料,已成功获批二类医疗器械注册证。
另一个扩充产品组合的重要里程碑,是基于集团的专利原料-Skbrella TM FN自主研发的医疗美容品牌-“肌颜态”的正式上市。肌颜态旨在提供安全有效的皮肤护理解决方案,以修复和改善皮肤质量,尤其是针对受损或敏感肌的患者。同时,集团正在推进基于纤连蛋白成分的医疗器械的研发。(sl/da)(港股报价延迟最少十五分钟。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.